Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies - Reply

被引：0

作者：

Roehrborn, CG ^{[1
]}

机构：

[1] Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75230 USA

来源：

BJU INTERNATIONAL | 2003年 / 92卷 / 09期

关键词：

D O I：

10.1111/j.1464-410X.2003.4537b.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1044 / 1045

页数：2

共 50 条

[1] Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies
Roehrborn, CG
Van Kerrebroeck, P
Nordling, J
BJU INTERNATIONAL, 2003, 92 (03) : 257 - 261
[2] Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A randomized, placebo-controlled trial
Roehrborn, CG
UROLOGY, 2001, 58 (06) : 953 - 959
[3] Safety and efficacy of alfuzosin 10mg once daily: A pooled analysis of three double-blind placebo-controlled studies
Roehrborn, CG
Van Kerrebroeck, PE
Nordling, J
JOURNAL OF UROLOGY, 2002, 167 (04): : 265 - 266
[4] Safety and efficacy of doxazosin in benign prostatic hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies
Roehrborn, CG
Siegel, RL
UROLOGY, 1996, 48 (03) : 406 - 415
[5] Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial
Porst, Hartmut
Kim, Edward D.
Casabe, Adolfo R.
Mirone, Vincenzo
Secrest, Roberta J.
Xu, Lei
Sundin, David P.
Viktrup, Lars
EUROPEAN UROLOGY, 2011, 60 (05) : 1105 - 1113
[6] Tadalafil 5mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies
Nishizawa, Osamu
Yoshida, Masaki
Takeda, Masayuki
Yokoyama, Osamu
Morisaki, Yoji
Murakami, Masahiro
Viktrup, Lars
INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (04) : 378 - 384
[7] Efficacy and safety of alfuzosin 10 mg once daily in the treatment of symptomatic benign prostatic hyperplasia
Kuritzky, L
Rosenberg, MT
Sadovsky, R
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (03) : 351 - 358
[8] Efficacy and Safety of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Subgroup Analyses of Pooled Data From 4 Multinational, Randomized, Placebo-controlled Clinical Studies
Porst, Hartmut
Oelke, Matthias
Goldfischer, Evan R.
Cox, David
Watts, Steven
Dey, Debashish
Viktrup, Lars
UROLOGY, 2013, 82 (03) : 667 - 673
[9] Re: Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial Editorial Comment
Seftel, Allen D.
JOURNAL OF UROLOGY, 2012, 187 (03): : 990 - 990
[10] Alfuzosin 10 mg once daily in the management of acute urinary retention: Results of a double-blind placebo-controlled study - Reply
McNeill, AS
UROLOGY, 2005, 65 (01) : 90 - 90

← 1 2 3 4 5 →